Trial Profile
A Pilot Phase 2 Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Advanced Malignant Mesothelioma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 May 2017
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 23 May 2016 Status changed from active, no longer recruiting to completed.
- 07 May 2015 Planned End Date changed from 1 Mar 2016 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 07 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.